Evidence map›Paper›PMID 36678743›Full record

ArticlePharmaceutics2022

Synthesis of Novel 1,3,4-Oxadiazole-Derived

Shaima Hkiri, Marwa Mekni-Toujani, Elvan Üstün, Karim Hosni, Abdeljelil Ghram, Soufiane Touil, Ali Samarat, David Sémeril

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
7.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Shaima HkiriSynthèse Organométallique et Catalyse, UMR-CNRS 7177, University of Strasbourg, 4 rue Blaise Pascal, 67008 Strasbourg, France.
Marwa Mekni-ToujaniLaboratory of Epidemiology and Veterinary Microbiology, LR19IP03, Institute Pasteur of Tunis, University of Tunis El Manar, BP 74, Tunis-Belvedere 1002, Tunisia.ORCID 0000-0001-9710-6933
Elvan ÜstünDepartment of Chemistry, Faculty of Science and Arts, University of Ordu, 52200 Ordu, Turkey.ORCID 0000-0002-0587-7261
Karim HosniLaboratoire des Substances Naturelles, Institut National de Recherche et d'Analyse Physico-Chimique (INRAP), Biotechpôle de Sidi Thabet, Ariana 2020, Tunisia.ORCID 0000-0003-0978-8378
Abdeljelil GhramLaboratory of Epidemiology and Veterinary Microbiology, LR19IP03, Institute Pasteur of Tunis, University of Tunis El Manar, BP 74, Tunis-Belvedere 1002, Tunisia.
Soufiane TouilLaboratory of Hetero-Organic Compounds and Nanostructured Materials, LR18ES11, Faculty of Sciences of Bizerte, University of Carthage, Bizerte 7021, Tunisia.ORCID 0000-0002-2878-5757
Ali SamaratLaboratory of Hetero-Organic Compounds and Nanostructured Materials, LR18ES11, Faculty of Sciences of Bizerte, University of Carthage, Bizerte 7021, Tunisia.ORCID 0000-0002-8334-7565
David SémerilSynthèse Organométallique et Catalyse, UMR-CNRS 7177, University of Strasbourg, 4 rue Blaise Pascal, 67008 Strasbourg, France.ORCID 0000-0002-2582-4191
Centre National de la Recherche Scientifique · FRTunis University · TNUniversity of Carthage · TNOrdu University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An efficient and simple approach has been developed for the synthesis of eight dialkyl/aryl[(5-phenyl-1,3,4-oxadiazol-2-ylamino)(aryl)methyl]phosphonates through the Pudovik-type reaction of dialkyl/arylphosphite with imines, obtained from 5-phenyl-1,3,4-oxadiazol-2-amine and aromatic aldehydes, under microwave irradiation. Five of them were hydrolyzed to lead to the corresponding phosphonic acids. Selected synthesized compounds were screened for their in vitro antiviral activity against the avian bronchitis virus (IBV). In the MTT cytotoxicity assay, the dose-response curve showed that all test compounds were safe in the range concentration of 540-1599 µM. The direct contact of novel synthesized compounds with IBV showed that the diethyl[(5-phenyl-1,3,4-oxadiazol-2-ylamino)(4-trifluoromethoxyphenyl)methyl]phosphonate (

Indexed as

1,3,4-oxadiazolecoronavirusinfectious bronchitis virusvirucidal activityα-aminophosphonateα-aminophosphonic acid

Identifiers

PMID36678743
PMCPMC9867332
OpenAlexW4313238070

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.